Metastatic prostate cancer remains uncurable. In this issue of , Rice et al. present an assessment of a compound (SU086) demonstrating activity in prostate cancer models through heat shock protein 90 inhibition and cell metabolism changes.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861633 | PMC |
http://dx.doi.org/10.1016/j.xcrm.2021.100493 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!